111 related articles for article (PubMed ID: 8299366)
1. Early detection of glucocorticoid-specific epidermal alterations using skin surface microscopy.
Schulz H; Nietsch KH; Höhler T
Curr Probl Dermatol; 1993; 21():132-9. PubMed ID: 8299366
[No Abstract] [Full Text] [Related]
2. Influence of glucocorticoid substances and the vehicle on skin irritancy: determination by profilometry.
Korting HC
Curr Probl Dermatol; 1993; 21():140-6. PubMed ID: 8299367
[No Abstract] [Full Text] [Related]
3. Side effects of topical glucocorticoids.
Mills CM; Marks R
Curr Probl Dermatol; 1993; 21():122-31. PubMed ID: 8299365
[No Abstract] [Full Text] [Related]
4. Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound.
Korting HC
Curr Probl Dermatol; 1993; 21():114-21. PubMed ID: 8299364
[No Abstract] [Full Text] [Related]
5. Suppression of induced inflammation in man.
Kerscher MJ
Curr Probl Dermatol; 1993; 21():97-106. PubMed ID: 8299382
[No Abstract] [Full Text] [Related]
6. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.
Korting HC; Vieluf D; Kerscher M
Eur J Clin Pharmacol; 1992; 42(2):159-61. PubMed ID: 1618247
[TBL] [Abstract][Full Text] [Related]
7. Local tolerability of topically applied methylprednisolone aceponate.
Kecskés A; Jahn P; Lange L
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):786-8. PubMed ID: 8496430
[No Abstract] [Full Text] [Related]
8. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
9. Influence of the base on the results of clinical trials with topical corticosteroids.
Vollum DI; Sparkes CG
Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
[TBL] [Abstract][Full Text] [Related]
10. Different skin thinning potential of equipotent medium-strength glucocorticoids.
Korting HC; Unholzer A; Schäfer-Korting M; Tausch I; Gassmueller J; Nietsch KH
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):85-91. PubMed ID: 11867964
[TBL] [Abstract][Full Text] [Related]
11. Facial telangiectasia associated with long-term application of a topical corticosteroid to the scalp.
Hogan DJ; Rooney ME
J Am Acad Dermatol; 1989 Jun; 20(6):1129-30. PubMed ID: 2754065
[No Abstract] [Full Text] [Related]
12. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial.
Wolf-Jürgensen P
Curr Med Res Opin; 1979; 5(10):779-84. PubMed ID: 373992
[TBL] [Abstract][Full Text] [Related]
13. Assessment of atrophy of human skin caused by corticosteroids using chamber occlusion and suction blister techniques.
Somerma S; Lassus A; Salde L
Acta Derm Venereol; 1984; 64(1):41-5. PubMed ID: 6203280
[TBL] [Abstract][Full Text] [Related]
14. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
Gysler A; Kleuser B; Sippl W; Lange K; Korting HC; Höltje HD; Korting HC
Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654
[TBL] [Abstract][Full Text] [Related]
15. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF;
Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334
[TBL] [Abstract][Full Text] [Related]
16. A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis.
Blum G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1153-6. PubMed ID: 1757607
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructure of murine epidermis treated with the vitamin D3 analogue KH-1060.
Kobayasi T; Gniadecki R; Serup J
Acta Derm Venereol; 1995 May; 75(3):222-7. PubMed ID: 7544521
[TBL] [Abstract][Full Text] [Related]
18. Steroid addiction.
Kligman AM; Frosch PJ
Int J Dermatol; 1979; 18(1):23-31. PubMed ID: 153891
[No Abstract] [Full Text] [Related]
19. Corticosteroid effect on epidermal cell size.
Delforno C; Holt PJ; Marks R
Br J Dermatol; 1978 Jun; 98(6):619-23. PubMed ID: 678451
[TBL] [Abstract][Full Text] [Related]
20. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
